50419-0392 VITRAKVI - CanMED: NDC

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Product Information

CanMED: NDC

Product NDC:

50419-0392

Brand Name:

VITRAKVI

Generic Name:

LAROTRECTINIB

Dosage Form Name:

SOLUTION, CONCENTRATE

Administration Route:

OROPHARYNGEAL

Substances:

Name: LAROTRECTINIB

Strength: 20.0

Unit: mg/mL

Packages:

Code: 50419-0392-01

Description: 100 mL in 1 BOTTLE (50419-392-01)

Effective Date: July 26, 2019

Discontinued:

SEER*Rx Category:

Chemotherapy

Major Class:

Tyrosine Kinase Inhibitor

Minor Class:

TRK

Orphan Drug Designation:

Status:

In Use